West-Ward Recalls Doxycycline Hyclate Tablets for Failed Dissolution Specifications
West-Ward Columbus Inc. is recalling Doxycycline Hyclate 100 mg tablets because they failed dissolution specifications.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which is a moderate risk. The hazard is a failure to meet dissolution specifications, which is a quality issue that may affect drug efficacy but does not involve a high-risk pathogen or immediate physical injury hazard like choking or fire.
Plain-English summary
West-Ward Columbus Inc. is recalling Doxycycline Hyclate Tablets, USP, 100 mg, 500-count bottles. The recall involves 29,048 bottles, containing a total of 14,524,000 tablets. The affected product is identified by Lot# 71545A and has an expiry date of 07/19.
The recall was initiated because the product failed dissolution specifications. This means the tablets may not dissolve in the body as intended, which could affect the delivery of the medication.
The product was distributed nationwide in the USA. Consumers and healthcare providers should check their inventory for the specific lot number and expiry date listed above. If the product is found, it should be returned to the pharmacy or point of purchase for a refund or replacement.
The recalled product
- Product
- DOXYCYCLINE HYCLATE (DOXYCYCLINE HYCLATE)
- Brand
- DOXYCYCLINE HYCLATE
- Manufacturer
- West-Ward Columbus Inc
- Category
- Drug — Antibiotic
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot# 71545A
- Expiry date: 07/19
UPCs (1)
- 0301432112508
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by West-Ward Columbus Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same brand · DOXYCYCLINE HYCLATE
- Moderate
- ModerateAmerican Health Packaging Recalls Doxycycline Hyclate Tablets for Dissolution Failure
FDA (Drugs) · 2020-06-17
- ModerateHarvard Drug Group Recalls Doxycycline Hyclate Tablets for Dissolution Failure
FDA (Drugs) · 2020-06-10
- ModerateWest-Ward Recalls Doxycycline Hyclate Tablets Due to Dissolution Failure
FDA (Drugs) · 2020-06-03
- ModerateAmerican Health Packaging Recalls Doxycycline Hyclate Tablets for Dissolution Failure
FDA (Drugs) · 2019-08-07
Same manufacturer · West-Ward Columbus Inc
See all →- ModerateMethadone Hydrochloride Tablets recalled for illegible product identification
FDA (Drugs) · 2025-01-15
- LowMethotrexate Sodium tablets recalled due to illegible markings and unsmooth surface
FDA (Drugs) · 2023-11-01
- LowWest-Ward Recalls Leucovorin Calcium Tablets With Incorrect Identification Code
FDA (Drugs) · 2020-08-19
- ModerateWest-Ward Recalls Ethacrynic Acid Tablets for Impurity Failures
FDA (Drugs) · 2020-05-27
- SevereWest-Ward Recalls Oxcarbazepine Oral Suspension Due to Impurity Failures
FDA (Drugs) · 2019-09-25
Same hazard · failed dissolution
See all →- ModerateNovartis Recalls Diovan Valsartan Tablets Due to Failed Dissolution Specifications
FDA (Drugs) · 2026-08-19
- LowSupernus Recalls Trokendi XR Capsules for Failed Dissolution Specifications
FDA (Drugs) · 2026-07-29
- HighAscend amlodipine and olmesartan tablets failed dissolution specifications
FDA (Drugs) · 2026-06-10
- HighLannett niacin extended-release tablets failed dissolution specifications during stability
FDA (Drugs) · 2026-06-10
- HighMajor Pharmaceuticals memantine extended-release capsules fail dissolution specifications
FDA (Drugs) · 2026-04-22